Tags » NPPA

Fortis row: Regulator who said hospitals inflated drug prices transferred

On March 1, 2018, Bhupendra Singh, the head of the National Pharmaceutical Pricing Authority (NPPA) with a year of his tenure left, was transferred to the National Authority for Chemical Weapons Convention, sparking protests from pro-access activists. 58 more words

Private Hospitals, Including Fortis, Making Profits up to 1737%: Drug Price Regulator’s New Study



The regulator’s study shows that the major beneficiaries of profits from inflated prices have been hospitals and not patients or manufacturers. 875 more words


Is It Time To Regulate Private Hospitals ?

No Wealth, No Health

A country that is hoping to launch the largest healthcare insurance scheme in the world, a long hard look in the mirror of its current state of health care is much needed.  782 more words


Ethics in Photojournalism

News images shape our culture in both profound and deep ways. Those who went through the Vietnam era couldn’t help but remember the daunting photographs that have come to symbolize that conflict. 678 more words

Stent price control: 5 reasons why 'high-end stent' companies might still hope

As the National Pharmaceutical Pricing Authority (NPPA) gets down to revisiting the prices of stents and discussing their makers’ grievances in February, here are five reasons why multinational stent companies selling relatively high-end products can still hope. 639 more words


Achievements of Ministry of Chemicals and Fertilizers during 2017

Year End Review- 2017: Ministry of Chemicals & Fertilizers



New Urea Policy – 2015 was notified on 25th May, 2015:- 2,997 more words

Is self-regulation in #medtech doomed to fail?

The offer by needle and syringe manufacturers to voluntarily cap trade margins at 75 per cent after meeting with the National Pharmaceutical Pricing Authority apparently validates the view that without the actionable threat of price control, the healthcare sector cannot be trusted to self-regulate. 1,269 more words